
    
      This is an open-label study with pediatric subjects, ages 2-12 years, who will be dosed with
      diclofenac potassium oral solution, based on weight, every 6 hours as needed for the
      treatment of mild to moderate acute pain for up to 4 days. PK samples will be collected
      through 6 hours after the first dose. Safety data will be collected throughout the study.
    
  